One-hour showcase of some of the most significant SWOG results presented at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO). Webinar was recorded June 26, 2024.
Featuring:
Dawn L. Hershman, MD, MS - Moderator
Meghna S. Trivedi, MD, MS - S1714 results: risk prediction model for taxane-induced peripheral neuropathy in patients with early-stage cancer
Kevin Kalinsky, MD, MS - anti-Müllerian hormone levels refine identification of premenopausal patients most likely to benefit from adjuvant chemo in S1007 RxPONDER
Lajos Pusztai, MD, DPhil - development and validation of RSClin N+ prognostic tool for HR+, HER2-negative, node-positive breast cancer
Joseph Unger, PhD - patient-reported fatigue and risk of treatment-related adverse events
Jill Hamilton-Reeves, PhD, RD, CSO - S1600 results: effects of immune-enhancing nutrition on radical cystectomy outcomes
Lee Ellis, MD - Moderator
30 июн 2024
